Flector tissugel used to treat capsular contracture after breast augmentation surgery.

Aesthetic plastic surgery 2008 Vol.32(3) p. 453-8

Le Louarn C, Buis J, Auclair E

관련 도메인

Abstract

Capsular contracture constitutes the main postoperative complication after breast augmentation by implant placement. To date, no systemic treatment known allows for improvement that does not simultaneously put the patient at risk for secondary complications of a more general nature. Flector Tissugel is the sole locally active antiinflammatory patch. Its durable local antiinflammatory effect is associated only with a risk for rare and highly limited side effects. After approximately 3 weeks of treatment, a high frequency of change from capsular contracture Baker 2 or 3 to Baker 1 occurs, provided the application was started no later than 3 months after the onset of capsular contracture.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
합병증 capsular contracture 피막구축 dict 4
시술 breast augmentation 유방성형술 dict 2
해부 breast 유방 dict 2
해부 capsular scispacy 1
약물 Tissugel scispacy 1
약물 Flector scispacy 1
질환 capsular contracture Baker 2 or 3 to Baker 1 scispacy 1
기타 patient scispacy 1
기타 patch scispacy 1

MeSH Terms

Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Breast; Breast Implants; Calcinosis; Contracture; Diclofenac; Female; Gels; Humans; Time Factors

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문